Colgate-Palmolive (CL) reported third-quarter 2026 sales of $5.369 billion, beating consensus estimates of $5.334 billion. Adjusted earnings per share came in at $0.97, above the Street's $0.93 projection.
Management raised its full-year 2026 base business EPS growth forecast to 5-7 percent and projected improvement in gross profit margins for the year. The beat signals pricing power holds and brand loyalty remains intact in household and personal care essentials.
For long-term investors, the margin expansion guidance matters most. Margin defense is notoriously difficult in consumer goods—it's where operational execution separates winners from laggards. Colgate's ability to hold or grow gross margins while beating top and bottom lines suggests the company is winning on pricing without losing volume.
The full-year EPS guidance upgrade is concrete: it's the company's committed earnings trajectory, not commentary. For staples investors who value consistency and downside protection, the beat-and-raise combo on earnings growth is the core catalyst worth monitoring.
